开发一种即时溶解的粉状作为透明液体,以缩短手术前的禁食时间
Alana Smaniotto Biolo1, Rafael Vinícius Patzer1, Rosicler Colet2
1School of Medicine, Universidade Regional do Alto Uruguai e das Missões, URI Erechim, Av. Sete de Setembro, 1621, 99709-910, Erechim, RS, Brazil.
Clinical nutrition ESPEN
|December 4, 2025
概括
一种新的透明减少了手术前的禁食,与手术后增强恢复 (ERAS) 协议保持一致. 这种安全和美味的选择可以在麻醉前两小时内食用,从而提高患者的满意度和恢复.
科学领域:
- 营养科学 营养科学
- 胃肠病学 胃肠病学
- 外科手术的协议.
背景情况:
- 长时间的手术前禁食会导致不适,胰岛素耐药性和延迟恢复.
- 手术后增强恢复 (ERAS) 和ACERTO协议建议在麻醉前2小时内饮用清洁液体.
- 富含碳水化合物的透明液体对于接受手术的患者来说是安全和有益的.
研究的目的:
- 开发和验证即时粉状作为透明液体,以缩短手术前的禁食时间.
- 创建一个美味和安全的替代传统的禁食协议.
- 与ERAS和ACERTO指南保持一致,以改善患者的治疗结果.
主要方法:
- 三种无脂肪,高热量配方使用马尔托德克斯,葡萄糖,化和味料来制备.
- 进行了微生物学,感官分析和物理化学表征.
- 在29名健康志愿者中,消费后2小时使用超声波评估胃空气.
主要成果:
- 选择的配方在微生物学上是安全的,pH值为5.17,水活性较低.
- 胃超声检查证实,在2小时内,所有参与者胃都被充分排空.
- 主观反表明满意度很高,60%的人报告感到足,75%的人没有口渴.
结论:
- 开发的透明是一种安全,美味和有效的选择,可以减少手术前的禁食.
- 这种创新,低成本的产品支持ERAS协议,并增强患者的康复.
- 潜在的应用包括医院环境和个性化营养治疗.
相关概念视频
One-Compartment Open Model for IV Bolus Administration: General Considerations
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant, half-life,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant, half-life,...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Modified-Release Drug Delivery Systems: Bioavailability
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...


